
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Edgewise Thera
Edgewise Therapeutics, Inc. operates as a biotechnology company. The Company develops novel, transformative therapies for the treatment of patients with debilitating diseases. Edgewise Therapeutics serves customers in the State of Colorado.
Stock Analysis

last close
$10.53
1-mo return
5.2%
3-mo return
41%
avg daily vol.
192.06T
52-week high
22.98
52-week low
5.41
market cap.
$531M
forward pe
-
annual div.
-
roe
-20.8%
ltg forecast
-
dividend yield
-
annual rev.
$--
inst own.
-